- UAA Congress 2025

Final Presentation Format

Non-Moderated Poster Abstract

Eposter Presentation

Eposter in PDF Format

Accept format: PDF. The file size should not be more than 5MB

Eposter in Image Format

Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB

Presentation Date / Time

Submission Status

Submitted

Abstract

Abstract Title

Role of antimuscarinics on low volume urine leakage after renal transplantation –A single center experience

Presentation Type

Podium Abstract

Manuscript Type

Clinical Research

Abstract Category *

Transplantation

Author's Information

Number of Authors (including submitting/presenting author) *

3

No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.

Country

Bangladesh

Co-author 1

Md Abu Sayed dmasayed@gmail.com Kidney Foundation Hospital & Research Institute Urology Dhaka Bangladesh *

Co-author 2

Masud Rana masud.jmc@gmail.com Bangladesh Medical College Urology Dhaka Bangladesh -

Co-author 3

Shakib uzzaman Arefin shakib04@yahoo.com Kidney Foundation Hospital & Research Institute Nephrology Dhaka Bangladesh -

Co-author 4

-

Co-author 5

-

Co-author 6

-

Co-author 7

-

Co-author 8

-

Co-author 9

-

Co-author 10

-

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Co-author 16

Co-author 17

Co-author 18

Co-author 19

Co-author 20

Abstract Content

Introduction

Urological complications, especially urine leakage, remain the most common type of surgical complication in the early post-transplant period. Tolterodine hydrochloride was used to observe the efficacy on low volume urine leakage.

Materials and Methods

A total of 16 living-related kidney transplant recipients were involved in this study who developed low volume urine leakage through drain tube from 1st to 2nd POD after transplantation. DJ stents and Foley catheter were kept in situ. Patients were divided into two groups. Group A was given tolterodine (4mg) daily and group B was not given

Results

Urine leakage stopped within 1 week of Group A. But leakage persisted 2-3 weeks of group B. The treatment also reduced the catheter related symptoms of group A.

Conclusions

Tolterodine, an anticholinergic medication used to treat overactive bladder, can potentially help to reduce urine leakage in individual’s post-renal transplant, as it relaxes the bladder muscles, also decrease the urge to urinate frequently.

Keywords

Tolterodine, Urine leakage

Figure 1

Figure 1 Caption

Figure 2

Figure 2 Caption

Figure 3

Figure 3 Caption

Figure 4

Figure 4 Caption

Figure 5

Figure 5 Caption

Character Count

0

Vimeo Link

Presentation Details

Session

Date

Time

Presentation Order